NSEInvestor Presentation▲ PositiveResults29 Oct 2026
Capital Small Finance Bank Limited
Investor Presentation
Capital Small Finance Bank Limited has released its investor presentation for the period ended September 30, 2026, highlighting its unaudited financial results, including a 23.4% YoY growth in loan book, 16.2% YoY growth in deposits, and a 31% YoY growth in profitability.
NSEInvestor Presentation▲ PositiveResults29 Oct 2026
Steamhouse India Limited
Investor Presentation
Steamhouse India Limited has submitted its Investor Presentation for Q2 & H1 FY27, highlighting a strong year-on-year performance despite seasonal moderation, with a 12.06% year-on-year growth in steam supply volumes and a focus on sustaining growth momentum.
NSEPress Release▲ PositiveResults29 Oct 2026
Strides Pharma Science Limited
Press Release
Strides Pharma Science Limited has announced its Q2FY27 financial results, with revenue growing 17% YoY to ₹14,297m, driven by Ex-US Markets, and EBITDA up 8% YoY to ₹2,509m, crossing ₹2,500m in a quarter for the first time.
BSECorp Action▲ PositiveResults29 Oct 2026
Sanofi India Ltd
Kindly refer the attachment
Sanofi India Ltd has announced its Q3 2026 financial results, reporting a 2% growth in domestic net sales and a 4% growth in total net sales. The company has also declared an interim dividend of Rs. 75 per equity share.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults29 Oct 2026
Kajaria Ceramics Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Kajaria Ceramics Limited reported 10% year-to-year volume growth in Q2 FY27, driven by better demand and market share gains. Consolidated revenue grew 24% year-to-year to INR1,468 crores, with EBITDA margin at 19.5%. The company's capacity expansion plans remain on track, and it expects to sustain healthy growth and strengthen its market position.
BSECompany Update▲ PositiveResults29 Oct 2026
Kajaria Ceramics Ltd
Transcript of Conference Call
Kajaria Ceramics Ltd reported 10% year-to-year volume growth in Q2 FY27, driven by better demand and market share gain. Consolidated revenue grew 24% YoY to INR1,468 crores, with EBITDA margin at 19.5%. The company's capacity expansion plans remain on track.
BSECorp. Action▲ PositiveResults29 Oct 2026
Sanofi India Ltd
Kindly refer the attachment
Sanofi India Ltd has announced its financial results for the quarter ended September 30, 2026, with domestic net sales growth of 2% and total net sales growth of 4% compared to the third quarter of 2025. The company has also declared an interim dividend of Rs. 75 per equity share for the financial year 2026.
BSECorp. Action▲ PositiveResults29 Oct 2026
Sanofi India Ltd
Kindly refer the attachment
Sanofi India Ltd declared an interim dividend of Rs. 75 per equity share for the financial year 2026, with a record date of November 5, 2026. The company also announced its unaudited financial results for the quarter and nine months ended September 30, 2026, with a 2% growth in domestic net sales and a 4% growth in total net sales compared to the third quarter of 2025.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults29 Oct 2026
TATA CONSUMER PRODUCTS LIMITED
Analysts/Institutional Investor Meet/Con. Call Updates
Tata Consumer Products Limited has announced its Q2 FY27 results, with revenue up 14%, EBITDA up 18%, and net profit at INR470 crores, growing 16%. The company's growth businesses, including Sampann and Ready-to-Drink, have shown strong performance, with Sampann up 57% and Ready-to-Drink strongly back on the growth trajectory with 47% growth.
BSECompany Update▲ PositiveResults29 Oct 2026
Tata Consumer Products Ltd
Enclosed.
Tata Consumer Products Ltd announced its Q2 FY27 results, with revenue up 14%, EBITDA up 18%, and net profit at INR470 crores, growing 16%. The company's growth businesses, including Sampann and Ready-to-Drink, had a strong quarter, with revenue up 57% and 47% respectively. The international business was impacted by shipping disruptions and the Mundra Port issue, but still grew 7% in constant currency.
BSECompany Update▲ PositiveResults29 Oct 2026
Sanofi India Ltd
Kindly refer the attachment
Sanofi India Ltd reported Q3 2026 financial results, with domestic net sales growth of 2% and total net sales growth of 4% compared to Q3 2025. The company's Insulin portfolio delivered 9% growth, and profits before tax and exceptional items rose 22% to INR 158 crores.
BSEBoard Meeting▲ PositiveResults29 Oct 2026
Sanofi India Ltd
Kindly refer the attachment
Sanofi India Ltd has announced its Q3 2026 financial results, reporting a 2% growth in domestic net sales and a 4% growth in total net sales compared to the third quarter of 2025. The company has also declared an interim dividend of Rs. 75 per equity share.
BSEResult▲ PositiveResults29 Oct 2026
Silver Touch Technologies Ltd
Find Enclosed herewith Un-Audited Financial Result for the Second Quarter and Half year ended 30th September, 2026
Silver Touch Technologies Ltd has announced its unaudited financial results for the second quarter and half year ended 30th September, 2026, with a net profit of Rs. 1306.42 crore and an interim dividend of Rs. 0.10 per equity share.
NSEOutcome of Board Meeting▲ PositiveResults29 Oct 2026
Sanofi India Limited
Outcome of Board Meeting
Sanofi India Limited has announced its unaudited financial results for the quarter and nine months ended 30th September 2026, reporting a 2% growth in domestic net sales and a 4% growth in total net sales compared to the third quarter of 2025. The company has also declared an interim dividend of Rs. 75 per equity share.
NSEPress Release▲ PositiveResults29 Oct 2026
Fiberweb (India) Limited
Press Release
Fiberweb (India) Limited has announced its unaudited Q2 FY27 financial results, with total income surging 209.36% QoQ to ₹30.99 Cr, EBITDA rising 76.77%, and net profit jumping 366.02%. The company has reported a PAT margin of 4.11% and EPS of ₹0.44.
BSEResult▲ PositiveResults29 Oct 2026
Sanofi India Ltd
Kindly refer the attachment
Sanofi India Ltd has announced its unaudited financial results for the quarter and nine months ended 30th September 2026, reporting domestic net sales growth of +2% and total net sales growth of 4% compared to the third quarter of 2025. The company has also declared an interim dividend of Rs. 75/- per equity share.
BSECompany Update▲ PositiveResults29 Oct 2026
Jupiter Life Line Hospitals Ltd
Q2 FY27 Earnings Conference Call - Transcript
Jupiter Life Line Hospitals Ltd has announced its Q2 FY27 earnings conference call transcript, highlighting a successful land acquisition for its Pune South hospital and positive financial performance. The company's income stood at INR456.5 crores in Q2, with an EBITDA of INR106.9 crores and a PAT of INR56.4 crores. The acquisition of the land is expected to provide control, certainty, and better long-term financial value.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults29 Oct 2026
Jupiter Life Line Hospitals Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Jupiter Life Line Hospitals Limited has announced its Q2 FY27 earnings, with income at INR456.5 crores, EBITDA at INR106.9 crores, and PAT at INR56.4 crores. The company has also acquired land for its Pune South hospital and is progressing well with its other projects.
BSECompany Update▲ PositiveResults29 Oct 2026
Fiberweb India Ltd
Pursuant to Regulation 30 of the SEBI (Listing Obligation & Disclosure Requirement) Regulation, 2015, please find attached herewith Press Release for Q2 FY 27 Results.
Fiberweb India Ltd has announced its Q2 FY27 financial results, with total income surging 209.36% QoQ to ₹30.99 Cr, EBITDA rising 76.77%, and net profit jumping 366.02%. The company has reported a PAT margin of 4.11% and EPS of ₹0.44.
BSECompany Update▲ PositiveResults29 Oct 2026
Brigade Enterprises Ltd
Investors Presentation Q2 FY 27
Brigade Enterprises Ltd has released its Investor Presentation for Q2 FY27, highlighting strong Q2 momentum in pre-sales and launch momentum, with planned launches of ~13 Mn sq. ft. over the next four quarters.